Navigation Links
Ovum Puts Linguamatics 'On the Radar'
Date:5/7/2013

CAMBRIDGE, England and BOSTON, May 7, 2013 /PRNewswire/ -- Text mining software vendor Linguamatics is proud to announce it is the subject of a special "On the Radar" report by award-winning industry analysts Ovum.  The report recognizes Linguamatics as a leader in text mining and predicts strong growth prospects for the company in the coming year.

Ovum believes the life sciences industry is facing significant challenges, including patent expirations, increased regulatory requirements, poor pipeline productivity, higher efficacy thresholds for reimbursement, and increased complexity across the drug lifecycle. These challenges are driving life sciences companies to improve productivity while reducing costs. Ovum believes Linguamatics' natural language processing-based knowledge discovery platform enables organizations to better leverage textual data, so as to achieve these goals.

Linguamatics I2E is noteworthy for its suitability for complex, high-value analysis of structured and unstructured text-based data sets. Report author Andrew Brosnan states: "As life science organizations are faced with an ever-increasing volume of scientific, medical and social media textual data that is both structured and unstructured, there is a pressing need for software that can help to manage and mine large text-based datasets. Linguamatics' I2E platform will be a valuable tool for fulfilling this objective."

Linguamatics growth has been "impressive" and the company has "carved out an impressive footprint in big pharma." The company has won contracts with nine of the top 10 pharma companies, the U.S. Food and Drug Administration (FDA) and increasingly customers in healthcare where mining of electronic health records can provide significant insights. The latest version of Linguamatics' software, I2E 4.0, provides a powerful web services application programming interface (AP
'/>"/>

SOURCE Linguamatics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
2. Adeptia Named a Value Leader in EMA Radar for Integration Technologies for Hybrid Cloud: Q4 2012
3. State-of-the-Art Novelda NVA6000 Impulse Radar Transceiver Finds Widespread Appeal and Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The Medical Innovation Impact Index (MI3), a ... medical innovation, has been developed at the Initiative ... University’s ( FDU ) Rothman Institute of Innovation and ... new FDA (Food & Drug Administration) draft guidance documents ... certain medical devices. , “The main impediment to ...
(Date:5/26/2015)... 26, 2015 Regenestem Network ... cells clinic in Buenos Aires, Argentina. The clinic will ... care specialist. Pastrana has assembled a multidisciplinary team of ... in her state-of-the-art Puerto Madero office. , The ... to phase IV clinical studies in cellular therapies, and ...
(Date:5/26/2015)... HILDEN, Deutschland, May 26, 2015 ... ®   ermöglicht klinischen Laboren ... dazugehöriger Berichte; Vorstellung auf den Konferenzen ClinGen, ... N.V. (NASDAQ: QGEN ; Frankfurt Prime ... QIAGEN Clinical Insight ® (QCI™) bekannt. ...
(Date:5/26/2015)... GERMANTOWN, Md. , May 26, 2015   Intrexon ... biology, announced today that Gregory Frost , Ph.D., Senior ... at the Jefferies 2015 Global Healthcare Conference on Wednesday, June ... Grand Hyatt in New York City . ... XON ) is Powering the Bioindustrial Revolution with Better ...
Breaking Biology Technology:Medical Innovation Impact Index Launched at Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) under the Rothman Institute 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6Intrexon to Present at the Jefferies 2015 Global Healthcare Conference 2
... ... one of three Department of Energy (DOE) bio-energy research centers, has selected Surety’s AbsoluteProof ... ... Surety, LLC , the leading provider of data integrity protection solutions , ...
... , WILMINGTON, Del. and CHARLOTTESVILLE, Va., Dec. 15 ... University of Virginia (UVa) in Charlottesville, today announced that ... enhance development of new treatments primarily for coronary artery ... disease (PAD). , (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , ...
... , , BRIARCLIFF MANOR, N.Y., ... meeting of the International Society for Medical Publication Professionals (ISMPP) ... London, UK. More than 100 attendees are expected at this ... publishers, medical writers and medical agencies to discuss the changing ...
Cached Biology Technology:Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2
(Date:5/18/2015)... , May 18, 2015 Fingerprint Cards ... FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one if its ... until and including Q3 2015 and the sensors will be ... Communicated order values for 2015 hereby amount to 740 MSEK ... 2015 of 140 MSEK and a number of smaller orders ...
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
(Date:5/11/2015)...  Through a well-rounded UAS delegation representing private industry, government, ... showing at AUVSI,s Unmanned 2015 conference last week in ... UAS industry met with over 200 hundred people ... the UAS ecosystem. "Our message is clear ... Aerospace Rich Knoll . "If you want to fly ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... SPRING HARBOR, N.Y. The appointment of James ... 1968 set off an explosive development of research at ... and wisely teams of investigators with diverse scientific interests. ... essays by the scientists involved tell the stories of ...
... on patients who have suffered a heart attack ... red yeast rice, Xuezhikang (XZK), reduced the risk ... surgery/angioplasty), cardiovascular mortality and total mortality by one-third ... double-blind study, was conducted on almost 5,000 patients, ...
... Comprehensive Cancer Center have modified a common chemotherapy drug to ... advance that will allow them to model and measure the ... The discovery, published June 8, 2008 in the early ... monitor the immune system at the whole body level ...
Cached Biology News:Watson-inspired innovation in research at Cold Spring Harbor Laboratory 2Study finds Chinese food good for your heart 2UCLA researchers develop new PET scanning probe that will allowing monitoring of the immune system 2UCLA researchers develop new PET scanning probe that will allowing monitoring of the immune system 3
Recombinant Feline IL-12/IL-23 p40...
Request Info...
Recombinant Equine IL-6...
dithiothreitol (DTT) Reactive Dyes and Chemicals Thiol-Reactive Dyes, Haptens and Quenchers Reducing Agents...
Biology Products: